Perspective Therapeutics ... (CATX)

AMEX: CATX · Real-Time Price · USD

2.46

0.01 (0.41%)

At close: May 01, 2025, 3:59 PM

2.48

1.02%

After-hours: May 01, 2025, 07:56 PM EDT

Perspective Therapeutics Income Statement

Financials in USD. Fiscal year is July - June.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017
Revenue	n/a	1.43M	7.1M	10.79M	10.05M	9.68M	7.31M	5.92M	4.76M
Cost of Revenue	n/a	n/a	5.47M	6.18M	4.93M	4.56M	4.27M	4.08M	3.92M
Gross Profit	n/a	1.43M	1.63M	4.62M	5.12M	5.12M	3.05M	1.84M	838K
Operating Income	10.46M	-40.94M	-15.18M	-7.39M	-3.44M	-3.48M	-5.28M	-6.73M	-6.31M
Interest Income	10.52M	934K	1.12M	119K	59K	30K	108K	29K	118K
Pretax Income	-81.38M	-40.11M	-14.67M	-7.27M	-3.39M	-3.45M	-5.14M	-6.7M	-6.16M
Net Income	-79.28M	-46.51M	-14.67M	-7.15M	-3.19M	-3.27M	-4.85M	-6.7M	-6.16M
Selling & General & Admin	26.61M	21.06M	14.21M	9.43M	7.13M	7.55M	6.85M	6.83M	6.23M
Research & Development	41.64M	21.31M	2.6M	2.58M	1.43M	1.13M	1.47M	1.75M	965K
Other Expenses	24.09M	n/a	n/a	n/a	n/a	-73K	2K	n/a	-48K
Operating Expenses	92.34M	42.38M	17.43M	12.01M	8.56M	8.6M	8.32M	8.57M	7.14M
Interest Expense	-48K	84K	n/a	119K	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	97K	3.23M	2.8M	2.44M	2.98M	2.68M	2.66M	2.31M
Cost & Expenses	n/a	42.38M	22.9M	18.19M	13.49M	13.16M	12.59M	12.65M	11.07M
Income Tax Expense	-2.1M	-2.65M	n/a	-119K	-199K	-177K	-294K	-29K	-145K
Shares Outstanding (Basic)	644.25K	26.76M	142.1M	141.99M	103.84M	67.6M	67.04M	55.16M	55.02M
Shares Outstanding (Diluted)	644.25K	26.76M	142.1M	141.99M	103.84M	67.6M	67.04M	55.16M	55.02M
EPS (Basic)	-123.06	-1.4	-0.1	-0.05	-0.03	-0.05	-0.07	-0.12	-0.11
EPS (Diluted)	-123.06	-1.4	-0.1	-0.05	-0.03	-0.05	-0.07	-0.12	-0.11
EBITDA	10.46M	-39.96M	-14.84M	-7.39M	-3.43M	-3.48M	-5.3M	-6.7M	-6.19M
EBIT	-81.42M	-40.94M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	n/a	981K	344K	248K	9K	147K	-24K	80K	68K